Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Immunovant, Inc. (IMVT)

38.86 -0.63 (-1.60%)
As of 10:05:10 AM EDT. Market Open.
Trade IMVT on Coinbase
Chart Range Bar
Loading chart for IMVT
  • Previous Close 39.49
  • Open 39.48
  • Bid 27.84 x 200
  • Ask 46.50 x 1000
  • Day's Range 38.64 - 39.48
  • 52 Week Range 14.58 - 45.42
  • Volume 171,942
  • Avg. Volume 1,266,546
  • Market Cap (intraday) 8.027B
  • Beta (5Y Monthly) 0.81
  • PE Ratio (TTM) --
  • EPS (TTM) -2.78
  • Earnings Date (est.) Nov 9, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 48.88

Immunovant, Inc., a clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases. It develops IMVT-1402, a human monoclonal antibody that inhibits neonatal fragment crystallizable receptor for graves' disease, rheumatoid arthritis, sjögren's disease, cutaneous lupus erythematosus disease, myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy. The company was founded in 2018 and is based in Durham, North Carolina. Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd.

immunovant.com

315

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Performance Overview

Trailing total returns as of 9/3/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

IMVT
52.87%
S&P 500 (^GSPC)
12.45%

1-Year Return

IMVT
132.69%
S&P 500 (^GSPC)
19.38%

3-Year Return

IMVT
61.98%
S&P 500 (^GSPC)
70.47%

5-Year Return

IMVT
331.30%
S&P 500 (^GSPC)
69.73%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY27
Revenue --
Earnings -153.22M
Profit Margin 0.00%

Q2

FY26

Q3

FY26

Q4

FY26

Q1

FY27

-150M
-100M
-50M
0
0.0%

Analyst Insights

View More

Analyst Price Targets

30.00 Low
48.88 Average
38.86 Current
66.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/4/2026
Analyst JP Morgan
Rating Action Maintains
Rating Overweight
Price Action Raises
Price Target 47 -> 50

Statistics

View More

Valuation Measures

Annual
As of 9/1/2026
  • Market Cap

    8.24B

  • Enterprise Value

    7.34B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    11.21

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -46.73%

  • Return on Equity (ttm)

    -80.10%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -538.22M

  • Diluted EPS (ttm)

    -2.78

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    797.8M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -238.7M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

38.86 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • Daily – Vickers Top Buyers & Sellers for 06/29/2026

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 04/14/2025

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 07/11/2024

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 04/22/2024

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: